February 02, 2026 Press ReleasesFox Rothschild IP Team Advises CSPC Pharmaceuticals in $18.5 Billion Licensing Agreement with AstraZeneca
October 21, 2025 Press ReleasesFox Rothschild IP Team Successfully Institutes IPR Trials For CSPC Pharmaceuticals